Skip to content
Menu

Coherus Oncology, Inc. CHRS

Full chart Compare
Set alert

Price alert · CHRS

All alert types
0.37 USD -0.02 (-4.47%)

Regular-session close

0.37 0.00 0.00%

After hours · Nov 20, 4:02 PM ET

0.3628 Day range 0.4084
0.3628 52-week range 2.62
YTD
-73.96%
1 year
-66.38%

Ownership

  • Institutions 70.3%
  • Insiders 1.38%
  • Public and other holders 28.3%
Held by insiders 1.38%
Held by institutions 70.31%
Float held by institutions 71.30%
Institutions 175

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Blackrock Inc.10.37%11,951,95317.09MSep 29, 2024
Vanguard Group Inc9.82%11,310,68216.17MSep 29, 2024
Rubric Capital Management LP9.03%10,400,00014.87MSep 29, 2024
Kohlberg Kravis Roberts & Co. L.P.2.64%3,036,0764.34MSep 29, 2024
Citadel Advisors Llc2.48%2,857,2084.09MSep 29, 2024
Geode Capital Management, LLC2.23%2,565,1453.67MSep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.98%3,434,6984.91MSep 29, 2024
iShares Russell 2000 ETF2.47%2,848,0454.07MOct 30, 2024
Vanguard Strategic Equity Fund1.48%1,705,5122.44MSep 29, 2024
Vanguard Explorer Fund, Inc.1.47%1,693,3032.42MJul 30, 2024
Vanguard Extended Market Index Fund1.20%1,386,5621.98MSep 29, 2024
Fidelity Small Cap Index Fund0.98%1,129,8931.62MAug 30, 2024

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

CHRS insiders
InsiderRelationLatest transactionDateShares held
LANFEAR DENNIS MChief Executive OfficerConversion of Exercise of derivative securityNov 21, 20231,251,340
MCMICHAEL BRYAN JOfficerStock Award(Grant)Jan 19, 202326,386
STILWELL MCDAVID H.Chief Financial OfficerStock Award(Grant)Jan 19, 2023104,243
VEXLER VLADIMIROfficerStock Award(Grant)Jan 19, 2023131,323
WAHLSTROM MATSDirectorStock GiftFeb 8, 202499,988